- Browse by Author
Browsing by Author "Wen, Xin"
Now showing 1 - 4 of 4
Results Per Page
Sort Options
Item FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats(Nature Publishing Group, 2016-07-08) He, Jian-Li; Zhao, Miao; Xia, Jing-Jun; Guan, Jian; Liu, Yang; Wang, Lu-Qi; Song, Dong-Xue; Qu, Mei-Yu; Zuo, Meng; Wen, Xin; Yu, Xue; Huo, Rong; Pan, Zhen-Wei; Ban, Tao; Zhang, Yan; Zhu, Jiu-Xin; Shou, Weinian; Qiao, Guo-Fen; Li, Bai-Yan; Department of Pediatrics, IU School of MedicineFibroblast growth factor-21 (FGF21) is closely related to various metabolic and cardiovascular disorders. However, the direct targets and mechanisms linking FGF21 to blood pressure control and hypertension are still elusive. Here we demonstrated a novel regulatory function of FGF21 in the baroreflex afferent pathway (the nucleus tractus solitarii, NTS; nodose ganglion, NG). As the critical co-receptor of FGF21, β-klotho (klb) significantly expressed on the NTS and NG. Furthermore, we evaluated the beneficial effects of chronic intraperitoneal infusion of recombinant human FGF21 (rhFGF21) on the dysregulated systolic blood pressure, cardiac parameters, baroreflex sensitivity (BRS) and hyperinsulinemia in the high fructose-drinking (HFD) rats. The BRS up-regulation is associated with Akt-eNOS-NO signaling activation in the NTS and NG induced by acute intravenous rhFGF21 administration in HFD and control rats. Moreover, the expressions of FGF21 receptors were aberrantly down-regulated in HFD rats. In addition, the up-regulated peroxisome proliferator-activated receptor-γ and -α (PPAR-γ/-α) in the NTS and NG in HFD rats were markedly reversed by chronic rhFGF21 infusion. Our study extends the work of the FGF21 actions on the neurocontrol of blood pressure regulations through baroreflex afferent pathway in HFD rats.Item Hydrophilic polymer‐coated PVC surface for reduced cell and bacterial adhesions(Wiley, 2022) Almousa, Rashed; Wen, Xin; Na, Sungsoo; Anderson, Gregory; Xie, Dong; Biology, School of ScienceHydrophilic polymers are very useful in biomedical applications. In this study, biocompatible polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP) polymers end‐capped with succinimidyl groups were either modified or synthesised and attached to polyvinylchloride surfaces. The modified surfaces were evaluated with cell adhesion and bacterial adhesion. 3T3 mouse fibroblast cells and three bacteria species were used to evaluate surface adhesion activity. Results showed that the modified surface exhibited significantly reduced 3T3 cell adhesion with a 50%–69% decrease for PEG and a 64%–81% for PVP, as compared to unmodified polyvinylchloride. The modified surface also showed significantly reduced bacterial attachment with 22%–78%, 18%–76% and 20%– 75% decrease for PEG and 22%–76%, 18%–76% and 20%–73% for PVP to Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, respectively, as compared to unmodified polyvinylchloride. It seems that an appropriate chain length or molecular weight (neither the longest nor the shortest chain length) determines the lowest cell and bacterial adhesion in terms of PEG. On the other hand, a mixture of polymers with different chain lengths exhibited the lowest cell and bacterial adhesion in terms of PVP.Item An improved dental composite with potent antibacterial function(Elsevier, 2019-07) Almousa, Rashed; Wen, Xin; Anderson, Gregory G.; Xie, Dong; Biomedical Engineering, School of Engineering and TechnologyA new BisGMA-based antibacterial dental composite has been formulated and evaluated. Compressive strength and bacterial viability were utilized to evaluate the formed composites. It was found that the new composite exhibited a significantly enhanced antibacterial function along with improved mechanical and physical properties. The bromine-containing derivative-modified composite was more potent in antibacterial activity than the chlorine-containing composite. The modified composites also exhibited an increase of 30–53% in compressive yield strength, 15–30% in compressive modulus, 15–33% in diametral tensile strength and 6–20% in flexural strength, and a decrease of 57–76% in bacterial viability, 23–37% in water sorption, 8–15% in shrinkage, 8–13% in compressive strength, and similar degree of conversion, than unmodified composite. It appears that this experimental composite may possibly be introduced to dental clinics as an attractive dental restorative due to its improved properties as well as enhanced antibacterial function.Item Polyurethane coated with polyvinylpyrrolidones via triazole links for enhanced surface fouling resistance(Wiley, 2021-12) Wen, Xin; Almousa, Rashed; Na, Sungsoo; Anderson, Gregory G.; Xie, Dong; Biomedical Engineering, School of Engineering and TechnologySurfaces with hydrophilic and antimicrobial properties are very attractive for cardiovascular device-associated applications. The aim of this study was to prepare and coat a hydrophilic polymer containing a functional group capable of forming triazole functionality onto the surface of polyurethane (PU). The modified surfaces were assessed with cell adhesion, bacterial adhesion and bacterial viability. Mouse fibroblast cells (NIH-3T3) and three bacterial species were used for assessment. The results showed that the modified surface not only exhibited a significant reduction in cell adhesion with a 25%–59% decrease to mouse fibroblast but also showed a significant reduction in bacterial attachment with 26%–67%, 24%–61% and 23%–57% decrease to Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, respectively, as compared with original PU. Furthermore, the polymer-modified surface exhibited a significant antibacterial function by inhibiting bacterial growth with reduction of 49%–84%, 44%–79% and 53%–79% to S. aureus, E. coli and P. aeruginosa, respectively, as compared with original PU. These results indicate that covalent polymer attachment enhanced the antibacterial and antifouling properties of the PU surface.